These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22700465)

  • 41. Intensity dependence of auditory evoked dipole source activity in polydrug ecstasy users: evidence from an 18 months longitudinal study.
    Daumann J; Till B; Fischermann T; Rezk M; Gouzoulis-Mayfrank E
    J Psychopharmacol; 2006 Mar; 20(2):236-44. PubMed ID: 16510481
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ecstasy (MDMA) and memory function: a meta-analytic update.
    Laws KR; Kokkalis J
    Hum Psychopharmacol; 2007 Aug; 22(6):381-8. PubMed ID: 17621368
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prospective memory functioning among ecstasy/polydrug users: evidence from the Cambridge Prospective Memory Test (CAMPROMPT).
    Hadjiefthyvoulou F; Fisk JE; Montgomery C; Bridges N
    Psychopharmacology (Berl); 2011 Jun; 215(4):761-74. PubMed ID: 21301817
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The differential effects of ecstasy/polydrug use on executive components: shifting, inhibition, updating and access to semantic memory.
    Montgomery C; Fisk JE; Newcombe R; Murphy PN
    Psychopharmacology (Berl); 2005 Oct; 182(2):262-76. PubMed ID: 16010539
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Auditory verbal learning in drug-free Ecstasy polydrug users.
    Fox HC; Toplis AS; Turner JJ; Parrott AC
    Hum Psychopharmacol; 2001 Dec; 16(8):613-618. PubMed ID: 12404541
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Visuospatial working memory deficits in remitted patients with bipolar disorder: susceptibility to the effects of GABAergic agonists.
    Pan YJ; Hsieh MH; Liu SK
    Bipolar Disord; 2011 Jun; 13(4):365-76. PubMed ID: 21843276
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Visuospatial memory impairments in users of MDMA ('ecstasy').
    Wareing M; Murphy PN; Fisk JE
    Psychopharmacology (Berl); 2004 May; 173(3-4):391-7. PubMed ID: 14735294
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential effects of ecstasy on short-term and working memory: a meta-analysis.
    Nulsen CE; Fox AM; Hammond GR
    Neuropsychol Rev; 2010 Mar; 20(1):21-32. PubMed ID: 20157852
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of 'ecstasy' (MDMA) on visuospatial memory performance: findings from a systematic review with meta-analyses.
    Murphy PN; Bruno R; Ryland I; Wareing M; Fisk JE; Montgomery C; Hilton J
    Hum Psychopharmacol; 2012 Mar; 27(2):113-38. PubMed ID: 22389076
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Auditory event-related potentials (P3) and cognitive performance in recreational ecstasy polydrug users: evidence from a 12-month longitudinal study.
    de Sola S; Tarancón T; Peña-Casanova J; Espadaler JM; Langohr K; Poudevida S; Farré M; Verdejo-García A; de la Torre R
    Psychopharmacology (Berl); 2008 Oct; 200(3):425-37. PubMed ID: 18581098
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Residual effects of ecstasy (3,4-methylenedioxymethamphetamine) on low level visual processes.
    Murray E; Bruno R; Brown J
    Hum Psychopharmacol; 2012 Mar; 27(2):226-34. PubMed ID: 22389087
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.
    Gouzoulis-Mayfrank E; Daumann J
    J Psychopharmacol; 2006 Mar; 20(2):188-93. PubMed ID: 16510477
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cortical oxygenation suggests increased effort during cognitive inhibition in ecstasy polydrug users.
    Roberts CA; Montgomery C
    J Psychopharmacol; 2015 Nov; 29(11):1170-81. PubMed ID: 26333432
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Electrophysiological indices of response inhibition in human polydrug users.
    Roberts CA; Fairclough S; Fisk JE; Tames FT; Montgomery C
    J Psychopharmacol; 2013 Sep; 27(9):779-89. PubMed ID: 23803689
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The influence of 5-HTT and COMT genotypes on verbal fluency in ecstasy users.
    Fagundo AB; Cuyàs E; Verdejo-Garcia A; Khymenets O; Langohr K; Martín-Santos R; Farré M; de la Torre R
    J Psychopharmacol; 2010 Sep; 24(9):1381-93. PubMed ID: 20080926
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of concurrent cannabis use among ecstasy users: neuroprotective or neurotoxic?
    Fisk JE; Montgomery C; Wareing M; Murphy PN
    Hum Psychopharmacol; 2006 Aug; 21(6):355-66. PubMed ID: 16915582
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term neuropsychological effects of ecstasy in middle-aged ecstasy/polydrug users.
    Schilt T; Koeter MW; Smal JP; Gouwetor MN; van den Brink W; Schmand B
    Psychopharmacology (Berl); 2010 Jan; 207(4):583-91. PubMed ID: 19823808
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Patterns of memory dysfunction in current and 2-year abstinent MDMA users.
    Ward J; Hall K; Haslam C
    J Clin Exp Neuropsychol; 2006 Apr; 28(3):306-24. PubMed ID: 16618622
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Investigating the role of serotonin in visual orientation processing using an 'ecstasy' (MDMA)-based research model.
    Dickson C; Bruno R; Brown J
    Neuropsychobiology; 2009; 60(3-4):204-12. PubMed ID: 19893337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.